Tag: aromataseInhibitors

Aromatase inhibitors: Drugs designed to inhibit the action of the enzyme aromatase, which converts androgens into estrogens within the body. Aromatase inhibitors are a type of first-line endocrine treatment for estrogen receptor positive (ER+) breast cancer.

Articles

News

08/26/17
Walking can reduce aromatase inhibitor-induced joint pain
01/12/15
Early birth control pill use linked to premenopausal BC recurrence
04/30/13
Side effects of anti-estrogens can indicate treatment is working
12/31/12
Treatment with Femara after tamoxifen can worsen cholesterol profile
07/19/12
Aromatase inhibitors are less effective in women with high BMI
03/08/12
Heart drug digoxin (digitalis) increases risk of breast cancer
02/06/12
Soy supplements do not reduce breast cancer risk and could be harmful
10/19/11
Tumor response to anti-estrogen treatment before surgery varies
07/17/11
Increasing aromatase inhibitor side effects make tamoxifen attractive
06/09/11
Patients with ER-/PR+ breast cancer benefit from endocrine therapy
11/18/10
Aromatase inhibitors have many potential side effects

Studies